Inverse correlation of concurrent BCL2, and C MYC expressions and CD30 ‎positivity as regard the Prognostic significance in diffuse large B-cell ‎lymphoma

Prognostic Significance of Concurrent MYC, BCL2 and/or BCL6 Expression in Diffuse Large B-Cell Lymphoma

Prognostic value of CD10, BCL6 and MUM1 in diffuse large B-cell lymphoma

EVALUATION OF NUCLEOLAR ORGANIZER REGIONS IN NON - HODGKIN'S LYMPHOMA

Relationship between C-MYC, BCL-2 and BCL-6 Genetic Abnormalities and Bone Marrow Biopsy in B-Non-Hodgkin Lymphoma

Lymphoid enhancer binding factor-1 (LEF1): as a prognostic factor in patients with Chronic lymphocytic leukemia

Prognostic value of BCL-2, cyclin E and cyclin dependent kinase inhibitor (P27) genes expression in non-Hodgkin lymphoma

Evaluation of survivin as a prognostic marker in head and neck lymphomas

PROGNOSTIC SIGNIFICANCE OF BCL-2, BAX AND P53 EXPRESSION IN BREAST CANCER

PROGNOSTIC VALUE OF CTBP2 AND CASP8AP2 EXPRESSION IN ADULT ACUTE B-CELL LYMPHOBLASTIC LEUKEMIA PATIENTS